Research Articles
Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.
Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression.
Perivascular Niche of Postnatal Mesenchymal Stem Cells in Human Bone Marrow and Dental Pulp.
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.
Differential Cell Surface Expression of the STRO-1 and Alkaline Phosphatase Antigens on Discrete Developmental Stages in Primary Cultures of Human Bone Cells.
The STRO-1 + Fraction of Adult Bone Marow contains the Osteogenic Precursors.
The Growth Factor Requirements of STRO-1 -Positive Human Bone Marrow Stromal Precursors under Serum-Deprived Conditions In Vitro.
Investor Centre
August 26 2010- Preliminary 2010 Annual Report
August 26 2010 - Mesoblast Financial Year End Results; Strong Clinical Progress, Major Regulatory Milestone and Enhanced Corporate Strategy
23 August 2010 - EGM documents - Letter from the Chairman, Notice of Meeting, Independent Expert Report.
16 August - Mesoblast on track for phase 3 bone marrow transplant trial following positive meeting with FDA
21 July - Mesoblast receives TGA regulatory approval to commercially manufacture adult stem cell products
12 July - Phase 3 meeting scheduled with FDA following positive results of bone marrow regeneration trial
28 May - Mesoblast featured at ASX Singapore conference highlighting emerging market leaders
19 May - United States FDA Clears Phase 2 Trial for Cervical Spinal Fusion
16 August 2010 - Southern Cross Equities research - Phase III getting ready for takeoff
23 July 2010 - Southern Cross Equities Research – Big Pharma will be watching
21 July 2010 - Southern Cross Equities Research – The clinical endgame nears
17 May 2010 - Southern Cross Equities Research – Capitalising the Stem Cell Opportunity
14 May 2010 - Bioshares
26 February - RBS Equities Research - Mesoblast (Buy) 1H10 - Master Blasters
July 2009 - Chairman’s Letter
May 2009 - Chairman’s Letter
May 2008 - Issue Nine
© Copyright Mesoblast Limited 2010. All rights reserved. Website design by Infoprobe Australia
disclaimer | privacy policy
home | contact | sitemap | Angioblast Systems | webmail the company | the technology | product development | investor centre | news room
